Live
Audio Only
This will allow health authorities to inoculate Argentines with a second dose as soon as possible without waiting for the importation of vaccines from Russia.
The Richmond pharmaceutical laboratory is producing Sputnik V vaccines in Argentina thanks to an agreement between President Alberto Fernandez's administration and the Russian Direct Investment Fund (RDIF).
RELATED:
The domestic manufacture of the COVID-19 vaccine will allow health authorities to inoculate Argentines with a second dose as soon as possible without waiting for the importation of Sputnik V from Russia.
At first, Richmond laboratory will produce 150,000 doses whose quality control will be carried out by the Russian Gamaleya Institute, which developed the Sputnik V vaccine.
In the next two months, the Fernandez administration aims to produce over one million vaccines following all health protocols.
A new batch of #SputnikV vaccines arrived in #Argentina pic.twitter.com/k7kITj0oqd
— Sputnik V (@sputnikvaccine) July 2, 2021
In December, the Fernandez administration launched the campaign to immunize 45 million inhabitants. In recent weeks, this health policy has accelerated thanks to the arrival of COVID-19 vaccines from different suppliers.
So far, Argentina has received 27.6 million doses, of which about 11 million correspond to the Sputnik V vaccine, over 6 million to the Sinopharm vaccine, and 7 million to AstraZeneca vaccine, whose active ingredient is also being produced domestically.
As of July 6, this South American country had reported 4,552,750 COVID-19 cases and 96,521 related deaths.
#Argentina | A shipment with the Sputnik V vaccine active ingredients has already arrived in Buenos Aires. pic.twitter.com/Nmj96b2V7O
— teleSUR English (@telesurenglish) June 14, 2021
Newsletter
